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Abstract

Objective
The purpose of this study is to evaluate the effect of balance training on disruptive
behaviors in children with Autism Spectrum Disorders (ASD).
Methods
Fourteen parents of children with ASD participated in this study. Data was
collected using the Aberrant Behavior Checklist (ABC) distributed to various therapy
centers around the Hattiesburg and Jackson areas. A secondary survey was included that
collected demographic data and basic data on what therapies the children have been
involved in. The ABC provided a measure of the incidence of disruptive behaviors
exhibited by the children with ASD as evaluated by their parents. Three of the five
subscales of the ABC were used including the irritability, stereotypy and hyperactivity
subscales all of which were treated as separate dependent variables. The demographic
data and list of therapies was used to investigate relationships between the therapies and
disruptive behaviors and to split the participants into the experimental and control groups.
The experimental group included those whose children had participated in balance
training for more than a year and the control group included those whose children
participated in balance training for less than a year. The data was analyzed using
Hotelling’s Trace and Independent Samples t-scores.
Results
When all three dependent variables were analyzed collectively there was no
statistically significant difference between the incidence of disruptive behaviors in the
control and experimental groups p>0.05. On a one-tailed independent samples t-test of
the individual variables none achieved significance between the groups p>0.05. When
the data was grouped based on number of interventions disregarding type, the score on
the irritability subscale just failed to reach significance with p=0.07.
Conclusion
None of the data was statistically significant even when analyzed for the effects of
ABA and drug treatments which does not reflect the findings of past research.
Limitations to this study include a small sample size, a quasi-experimental design, a lack
of baseline measures, a lack of representation of patients without access to high quality
therapeutic care, and a compromised control group which had to include individuals with
less than a year of balance training. Future research with a larger sample and a stronger
methodology is necessary to determine the effect of balance training on disruptive
behavior in children with ASD. Further research may also need to investigate the link
between number of therapies and disruptive behaviors.
Key words: Autism Spectrum Disorders, balance training, Aberrant Behavior Checklist,
disruptive behavior
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Chapter 1: The Problem

Autism spectrum disorders (ASD) are a group of pervasive neurological disorders
described by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition,
Text Revision (DSM-IV-TR) as having three core features: impaired social functioning,
delayed or abnormal communication skills, and stereotyped behaviors (American
Psychiatric Association, 2013). While the core symptoms of ASD are clearly defined,
other related symptoms and developmental abnormalities have been shown to be
pervasive among the population of individuals with ASD. Such symptoms can include
disruptive and maladaptive behaviors (Matson & Nebel-Schwalm, 2007), sensory
integration difficulties (Dawson & Watling, 2000), impaired fine and gross motor skills
(Baranek, 2002), and impaired balance (Fournier, Amano, Radonovich, Bleser, & Hass,
2014; Memari, Ghanouni, Gharibzadeh, Eghlidi, Ziaee, & Moshayedi, 2013; Fournier,
Kimberg, Randovich, Tillman, Chow, Lewis, Bodfish, & Hass, 2010; Romero-Munguía,
2008; Minshew, Sung, Jones, & Furman, 2007; Schmid, Conforto, Lopez, & D’Alessio,
2007; Gowen, & Miall, 2005; Molloy, Dietrich, & Bhattacharya, 2003). The disruptive
behaviors commonly exhibited by children with ASD include, but are not limited to, selfinjurious behavior, stereotypies, noncompliance, and aggression (Matson & NebelSchwalm, 2007). While disruptive behaviors are not considered part of the core
symptoms of ASD, the incidence of these behaviors is significant among this population
and should not be ignored in the body of research developing around the characteristics
and treatment of ASD (Matson & Nebel-Schwalm, 2007).
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Disruptive behaviors prevent children with ASD from participating in educational
and community activities (Machalicek, O’Reilly, Beretvas, Sigafoos, & Lancioni, 2007).
Elliot, Dobbin, Rose, and Soper (1994) suggest that maladaptive behaviors, such as
aggression and self-injury, prevent integration into the community and can prompt the
decision to place the individual into a restrictive residential center while also prolonging
their stay in such facilities. It is also important to note that stereotypical behaviors
prevent individuals with ASD from learning and completing tasks in vocational settings
even in the absence of aggression or self-injury (Elliot et al., 1994). These findings
suggest that children with ASD who exhibit these disruptive behaviors are more likely to
be excluded from inclusive learning environments preventing them from learning and
practicing valuable social and communication skills.
Currently the only research-based treatments for the symptoms commonly
associated with ASD are applied behavior analysis (ABA) and second generation,
sometimes called “atypical,” anti-psychotic medications. The only research which has
consistently investigated the effect treatment has on disruptive behaviors exhibited by
children with ASD pertains to psychopharmacological interventions (Matson & NebelSchwalm, 2007).
Some of the earliest research concerning strategies for overcoming the unique
behavioral challenges presented by children with ASD was conducted by Ivar Lovaas in
1973 (Lovaas, Koegel, Simmons, & Long, 1973). Based on the results of this small scale
1973 study, Lovaas conducted a larger scale experiment in 1987. In the original 1973
experiment Lovaas used the principles of ABA, a revolutionary treatment at the time, to
teach language to children with Autistic Disorder who exhibited behavioral problems
2

serious enough to impede learning (Lovaas et al., 1973). He found that he was able to
increase the receptiveness of the children to learning through using the technique (Lovaas
et al., 1973). In the 1987 experiment, Lovaas put a group of children with Autistic
Disorder through an intensive behavioral modification program and tracked the
improvements in their educational and intellectual functioning over an extended period of
time (Lovaas, 1987). Lovaas observed some reduction in the incidence of disruptive
behaviors in the children studied, however the majority of subsequent studies conducted
into ABA since Lovaas’ original study do not target disruptive behaviors as the target
variable for improvement through behavioral intervention (Matson & Nebel-Schwalm,
2007). A critique of Lovaas’ 1987 study by Schopler, Short, and Mesibov in 1989
suggested that the results of Lovaas’ study could not be determined due to failures in his
research procedure, namely poor choices of outcome measures, biased subject selection
criteria, and an inappropriate method for assigning control groups. The authors state that
since Lovaas had no quantifiable way to measure the gains made by the children in his
intervention it was impossible to tell if the children actually improved (Schopler et al.,
1989). Despite the doubts raised about Lovaas’ original methods research into ABA
continued eventually resulting in ABA becoming the preferred treatment method for
children with ASD.
The more recent research into ABA has focused primarily on addressing deficits
in intellectual functioning, language development, daily living skills, and social
functioning among children with ASD (Virues-Ortega, 2010). A number of studies have
shown improvement in these areas associated with the application of long-term intensive
ABA treatment, with improvements in language found to be the most dramatic (Virues3

Ortega, 2010). A common element of ABA research is a focus on children with autistic
disorder as opposed to a focus on ASD as a whole. Within the studies reviewed by
Virues-Ortega (2010) it was found that fifteen of the twenty two studies included focused
solely on children diagnosed with autistic disorder and seven also included children with
pervasive developmental disorder not otherwise specified (PDD-NOS). None of the
studies included children diagnosed with Asperger’s syndrome or Rett’s syndrome
(Virues-Ortega, 2010). This is a failure of the literature because all of the children on the
autism spectrum exhibit similar challenges and deficits and as such they should all be
researched equally to determine the efficacy of interventions rather than researching one
specific diagnostic group and generalizing to the others.
Some research has been conducted into interventions that are based on ABA
principles but do not precisely follow the methodology of ABA. A review of these
interventions used to decrease disruptive behaviors in a school setting found positive
results (Machalicek et al., 2007). The authors found that in the various studies reviewed
specific interventions were used to target individual disruptive behaviors (i.e. stereotypy,
aggression, non-compliance, and self-injury) as opposed to using one generalized
intervention designed to reduce all stated problem behaviors at once (Machalicek et al.,
2007). The authors do not see this approach as a problem, however from a practical
standpoint it is not feasible in a normal school setting to conduct a separate intensive
intervention for each challenging behavior a child with ASD presents.
While ABA research has rarely targeted disruptive behaviors, research into the
use of atypical anti-psychotic medications has targeted these behaviors nearly
exclusively. Currently the only medications in the class that are approved for use in
4

children with ASD are risperidone and aripiprazole (Pringsheim, Lam, Ching, & Patten,
2011). The use of atypical anti-psychotic medication to reduce disruptive behaviors in
autistic children has increased greatly over the past few decades (Posey, Stigler,
Erickson, & McDougle, 2008). The majority of studies conducted concerning the use of
atypical anti-psychotics have focused on the use of risperidone for children with ASD
(Posey et al., 2008).
In multiple placebo-controlled, double blind studies risperidone has been found to
be effective in treating a class of behaviors termed “irritability.” (Sharma & Shaw, 2011;
Scott & Dhillon, 2007; Jesner, Aref-Adib, & Coren, 2007; West & Waldrop, 2006; Shea
et al., 2004; McCracken et al., 2002). This “irritability” is a blanket term for the
disruptive behaviors commonly exhibited in children with ASD. Most studies show
improvements in irritability over short-term treatment with risperidone, however not
many long-term studies have been conducted (Troost et al., 2005). It is important for the
long-term effects of risperidone to be established because a growing number of children
are being prescribed risperidone as a permanent treatment option despite the lack of
research concerning the safety of its use over a long period of time (Troost et al., 2005).
A study conducted on the “long-term” effects of risperidone ran a trial for only six
months and found improvements in irritability and minimal side effects (predominantly
weight gain) (Troost et al., 2005). From an outside perspective, six months does not
seem to be a sufficient amount of time to determine the long-term effects this drug class
has on children with ASD. The findings on aripiprazole are similar; however less
research has been conducted into the use of this drug with this population (Marcus et al.,
2009).
5

This class of medications is known to have serious side-effects. The most
common side-effect discussed is weight gain; however, others exist (Pringsheim et al.,
2011). Risperidone and aripiprazole were both found to have negative metabolic and
neurological effects in children with the neurological effects being the more serious of
the two (Pringsheim et al., 2011). The authors suggest that while these medications have
been shown to decrease disruptive behaviors in children, their use should be closely
monitored and discontinued if serious side effects begin to arise (Pringsheim et al., 2011).
While there is a large body of research into ABA and psychopharmacological
interventions, there is little investigation into the more unconventional treatment methods
including sensory integration therapy, auditory integration training (AIT), sensorimotor
handling techniques, and antecedent physical exercise (Baranek, 2002; Dawson &
Watling, 2000). The research that does exist using these methods is predominantly
inconclusive (Dawson & Watling, 2000) with the most consistent positive gains seen
through the incorporation of antecedent aerobic exercise into the intervention strategy
(Baranek, 2002). Since these interventions have been proven neither ineffective nor
effective further research into these and other alternate strategies for behavioral
intervention in ASD is imperative (Baranek, 2002).
From the available body of research it is clear that alternative intervention
methods for reducing disruptive behaviors are necessary. Disruptive behaviors are rarely
addressed as a therapeutic goal in ABA, psychopharmacological treatments can be
dangerous and are not a permanent solution, and the less common treatment methods
have not been appropriately researched and have inconclusive findings (Pringsheim et al.,
2011; Matson & Nebel-Schwalm, 2007; Baranek, 2002; Dawson & Watling, 2000).
6

None of these intervention methods attempt to address the core symptoms of autism as a
unit, they all try to reduce specific behaviors. It makes sense that since these symptoms
are nearly universal among children with ASD that they are all related and an
improvement in one area will trigger positive gains in others, however no research has
been found to support that theory.
One of the most common symptoms found in individuals across the range of
disorders included in the autism spectrum is a lack of balance (Fournier, et al., 2014).
The postural control mechanism in children with ASD neither develops properly nor at
the same rate as that of typically developing children (Minshew et al., 2007). These
developmental deficits lead to reduced postural stability even in adulthood (Gowen &
Miall, 2005). Notably, research shows that deficits in postural control are not related to
the presence of co-morbid mental retardation (MR), as postural control problems were
found with equal frequency and severity among children with ASD with and without comorbid MR (Fournier et al., 2010). Two studies have been conducted into the effect of
cognitive tasks on balance in children with ASD, and they both found that postural
stability decreased with the inclusion of a concurrent cognitive task (Romero-Munguía,
2008; Schmid et al., 2007). From these findings it can be inferred that poor balance
interferes with the execution of complex cognitive tasks just the same way that these
cognitive tasks have been found to affect balance. This is an important finding because it
suggests that improving the balance of children with ASD has the possibility of
improving their ability to focus on, and carry out complex cognitive tasks such as
learning, speaking, and controlling their own disruptive behaviors. No research has been
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conducted on the effect balance training has for children with ASD despite the clear
evidence that this population has serious deficits in balance and postural control.
It is not readily apparent what causes children with ASD to exhibit disruptive
behaviors; however, it is clear that certain situations and demands placed on the child for
learning, or even a specific type of conduct (sitting still, being quiet, complex motor and
cognitive tasks), have the potential to aggravate the underlying causes of disruptive
behaviors in these children resulting in increased incidence of these behaviors (Matson &
Nebel-Schwalm, 2007). It is important that safe and effective treatment methods aimed
at reducing these behaviors be developed. According to a survey conducted by the
United States Centers for Disease Control in 2014, the incidence of ASD in the
population is increasing. The prevalence rates of ASD have increased from one in eighty
eight children in the 2012 survey to one in sixty eight children in 2014 (US Centers for
Disease Control, 2014; Baio J., 2012). This increase in prevalence makes it imperative
that strategies are developed both for how to teach children with ASD to interact
appropriately with society as well as how to manage their particular reactions to
environmental and activity-based stimuli.
Balance training could provide an effective alternative treatment option for
children with ASD; however, this particular subject has never been researched before.
This conspicuous lack of research makes it imperative for investigation into this topic to
be conducted. This study addresses the question: what is the effect of balance training on
disruptive behaviors in children with ASD?
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Chapter 2: Literature Review

The purpose of this study is to investigate the effect of balance training on
disruptive behaviors in children with ASD. According to the DSM-IV-TR, ASD are a
group of developmental disorders including autistic disorder, childhood disintegrative
disorder, Asperger’s syndrome, Rett’s disorder, and PDD-NOS which are all
characterized by three core symptoms: communication impairment, social impairment,
and stereotypical behaviors (American Psychiatric Association, 2000). A great deal of
research has been conducted pertaining to the best methods for managing the disruptive
behaviors commonly exhibited by children with these disorders because disruptive
behaviors can limit individuals with ASD from participating in community activities both
as children and adults (Matson, Sipes, Fodstad, & Fitzgerald, 2011). Some of the most
commonly investigated disruptive behaviors include aggression, non-compliance,
stereotypical behaviors, and self injurious behavior. Through the currently available
research, a few popular and evidence-based methods for managing these disruptive
behaviors have emerged including ABA, psychopharmacological interventions, and a
poorly researched group of “other” interventions.
Applied Behavior Analysis
Myers and Johnson (2007) discuss the use of ABA interventions and their relative
efficacy in a review of ABA literature. They define ABA as “applying interventions that
are based on the principles of learning derived from experimental psychology research to
systematically change behavior and to demonstrate that the interventions used are
responsible for the observable improvement in behavior (Myers & Johnson, 2007).” The
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authors discuss that ABA has been found effective in improving Intelligence Quotient
(IQ), language, academic performance, and adaptive behavior for the children who
participate in ABA programs (Myers & Johnson, 2007). Significantly, consistent positive
outcomes cited for ABA treatment do not include a considerable decrease in disruptive
behaviors, only gains in the functional areas previously discussed. The authors did find
that psychopharmacology has been reported to be a useful intervention to reduce
disruptive behaviors, with risperidone being the best supported agent, while other
interventions such as sensory and motor therapies were found to be poorly researched
with inconclusive results at best (Myers & Johnson, 2007).
Matson and Nebel-Schwalm’s 2007 study supports the concept that the literature
on ABA neglects to report improvements, if any occurred, in disruptive behaviors. They
found that the presence of disruptive behaviors is rarely assessed or included as an
outcome measure in studies of the use of ABA with autism despite considerable attention
to disruptive behaviors in studies involving children with Intellectual Disabilities (Matson
& Nebel-Schwalm, 2007). Conversely, the research into psychopharmacological
interventions for children with ASD has focused almost entirely on the reduction of
disruptive behaviors using as the primary behavioral marker “irritability,” which is
defined as aggression, self-injury or tantrums (Matson & Nebel-Schwalm, 2007; Matson
et al., 2011). This is an interesting dichotomy present in the research because it suggests
that these two major areas of study have begun to diverge from each other in terms of
what problems they chose to target with therapeutic intervention.
One of the primary concerns for the management of these disruptive behaviors is
how to best address them in the context of a school setting. Children with ASD must
10

attend school, but the disruptive behaviors exhibited by these children can seriously
impede the learning process for not only them but also their peers. Machalicek, O’Reilly,
Beretvas, Sigafoos, and Lancioni (2007) reviewed the most commonly used strategies for
managing these behaviors in school settings. None of the strategies reported are directly
ABA based, but rather include intervention strategies termed “eclectic” by the ABA
literature. These included antecedent manipulations, change in instructional context,
differential reinforcements, and self-management. Despite not being ABA based, almost
all of the studies reviewed had positive results (Machalicek et al., 2007). Upon further
investigation into these results, however, it was found that the effectiveness of the
interventions may have been overestimated by the strategies used by the original
researchers to report the results (Machalicek et al., 2007). The body of ABA research
suggests that positive effects from eclectic interventions are either non-existent or
negligible in comparison with ABA itself thus indicating that ABA may be a better
intervention for use in a school setting to improve learning. In a meta-analysis conducted
by Virues-Ortega in 2010 ABA was found to be effective in greatly improving language
related measures such as IQ, receptive and expressive language, and communication as
well as demonstrating lesser gains in non-verbal IQ, social functioning, and daily living
skills. It was also found that the amount of improvement seen on these measures was
directly related to the hours of intervention provided to the child with greater hours
corresponding to greater gains and vice versa (Virues-Ortega, 2010).
The use of ABA for children with ASD was pioneered by Ivar Lovaas in 1973. In
his initial study, Lovaas used ABA to teach language skills to children with autism who
exhibited behavioral problems serious enough to impede learning, and he found that he
11

was able to increase the receptiveness of the children to learning through using the
technique (Lovaas et al., 1973). Based on the results of this study, Lovaas conducted a
larger study in 1987. In this study thirty-eight children, who Lovaas claimed to have
average or below-average functionality, were placed into two groups; an intensive
treatment group who received a minimum of forty hours per week of intensive
intervention, and a control group who received only ten hours per week of treatment
(Lovaas, 1987). Lovaas claimed that by the end of the two year treatment period,
forty-seven percent of the children in the experimental group achieved “normal”
functioning and were considered “recovered” (Lovaas, 1987). Lovaas supported these
claims through the gain in IQ post treatment and the placement of these children into
mainstream first grade classrooms without an individual aid (Lovaas, 1987).
The intervention procedure employed by Lovaas has become the gold standard as
well as the basis for ABA programs throughout the world despite the presence of some
clear deficits in his study. Some of these deficits were investigated by Schopler, Short,
and Mesibov in 1989. The most serious problems with Lovaas’ research include
inappropriate, or absent, outcome measures, subject selection bias, and an inadequate
control group (Schopler et al., 1989). In Lovaas’ study no empirical measures of
functioning were taken. Level of functioning was measured instead using the classroom
placement of the children; a measure that has more to do with advocacy and educational
politics than with the children involved (Schopler et al., 1989). The only empirical
measure used was the improvement of scores on the IQ test which could suggest
improvement in compliance and test taking skills rather than a positive effect of the
intervention (Schopler et al., 1989). The authors also found that the subjects selected for
12

the study were of relatively high functioning and had good prognosis despite Lovaas’
claims to the contrary (Schopler et al., 1989). Thus, it can be concluded that the results
of Lovaas’ study cannot be determined due to serious methodological problems; this is a
particularly disturbing revelation considering that all of the research that has been
conducted since then has been based on Lovaas’ study.
In an attempt to combat these criticisms, a study was conducted on the long-term
effects of Lovaas’ intervention by conducting a six-year follow-up with the children who
were included in the original experiment. This study, conducted by McEachin, Smith and
Lovaas in 1993 used a number of empirical tests to assess functioning, an element that
was lacking in the original study. They found that the children in the experimental group
overall had maintained their classroom placement as well as IQ gains over the control
group; they also had comparatively higher rates of adaptive behaviors and lower
incidences of maladaptive behaviors as assessed by a “Clinical Rating Scale” developed
specifically for the study (McEachin et al., 1993). Ironically, this study was also
challenged in 2005 by Victoria Shea. Shea discusses that the results on the empirical
tests are not reported accurately as many measures are missing for some of the children
and only one of the “best outcome” subjects scored in the normal range on all of the tests
despite claims by McEachin and Lovaas that all of the children achieved normal
functioning (Shea, 2005). Shea also suggests that the much cited forty-seven percent
success rate of this intervention should not be taken too seriously due to the
methodological limitations of the original 1987 study and the inability for any subsequent
research to replicate this finding (Shea, 2005). Another element to consider when
evaluating the effectiveness of Lovaas’ treatment is that while these studies show the
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functioning of children who underwent the intervention to improve, they still remained
significantly impaired post-treatment (Shea, 2005). Of the available research into ABA,
only one study was found which approximates the level of success of Lovaas’ 1987
experiment. This study, conducted by Sallows and Graupner in 2005 found that of the
twenty-four children involved in the study, forty-eight percent were placed in regular
education classrooms and had average post-treatment scores. Success in this study was
predicted by high pre-treatment scores for IQ, imitation, language and social
responsiveness (Sallows & Graupner, 2005). This finding suggests that children with
ASD who are high-functioning may benefit more from ABA treatment than the majority
of the population of children with ASD.
Two other studies also found that rates of success in ABA programs are directly
linked to the pre-treatment level of intellectual functioning and autism severity of the
children involved (Weiss, 1999; Ben-Itzchak & Zachor, 2007). This finding is significant
because it indicates that ABA may not be as effective for the low-functioning population
of children with ASD despite what is implied by most of the other literature.
Some other problems with ABA discussed in the literature include: the necessity
of starting intervention programs before the age of four in order to have a significant
positive effect, concerns about long-term efficacy, and a concern over the different levels
of efficacy of clinic based, community based, and home based interventions, as well as
the expense of these programs in general (Schoen, 2003). Eikeseth, Smith, Jahr, and
Eldevik in 2002 addressed the first problem. Their study was conducted on children who
started intervention in a school setting between four and seven years old and the authors
found that the children who underwent the behavior intervention improved more than a
14

control group receiving “eclectic” therapies on measures of IQ, language, and adaptive
behaviors, thus indicating that these therapies are effective on older children (Eikeseth et
al., 2002). A follow-up study conducted a year after the cessation of treatment by the
same authors found that the gains made during the intervention program for the
behavioral group were maintained after the cessation of treatment (Eikeseth, Smith, Jahr,
& Eldevik, 2007).
Similarly, a study conducted on a group of twenty-three children who were placed
into an ABA program and twenty-one children receiving treatment as usual discovered
that the children in the ABA group improved more on measures of IQ, language, daily
living skills, and social behavior than did the control group (Remington et al., 2007). In
contrast to the outcome study conducted by Eikeseth et al. (2007), a two year follow-up
study conducted by Kovshoff, Hastings, and Remington in 2011, found that the gains in
all of the major outcome measures were lost two years after the cessation of treatment in
the group that participated in the ABA program. The authors were not able to account for
what caused their findings due to the presence of too many conflicting variables some of
which may have contributed to their results (Kovshoff et al., 2011). These inconclusive
findings on the long-term efficacy of ABA treatment prevent a decisive answer as to
whether or not the gains made during treatment are permanent in the children who
undergo these programs.
Much research has been conducted to investigate the efficacy of community and
parent-managed programs as compared to clinic based programs. Two studies conducted
with children in mainstream pre-school and kindergarten settings found that community
based programs are effective in improving adaptive behaviors, maladaptive behaviors,
15

IQ, and autism symptoms in participating children (Eikeseth, Kintwall, Jahr, & Karlsson,
2012; Eldevik, Hastings, Jahr & Hughes, 2012). A study conducted on the long-term
effects of ABA based on if an individualized intervention was conducted in a home-based
setting or a generalized treatment program was conducted in a nursery based setting,
found that the home-based individualized ABA treatment did not have significantly better
outcomes than the general nursery-based treatment either at the conclusion of treatment
or during the follow-up evaluation (Magiati, Charman, and Howlin, 2007). This is a
significant finding because it is the only study that indicates that the ABA treatment may
not be consistently effective for all populations. The study supports the notion that no
intervention that is “universally superior” to other interventions in the treatment of ASD
(Magiati et al., 2007). These findings however only reflect a single study and could have
been influenced by any number of unexpected factors.
Multiple studies have proven clinic based ABA treatment is equivalent to parent
managed treatment and that both are superior to the “eclectic” treatment method. In one
such study, intensive ABA treatment was compared to “eclectic” treatment, and the
intensive ABA treatment was seen to have greater gains in language and communication;
however, the number of hours dedicated to the eclectic treatment was not equal to that of
the ABA treatment which prevents ruling-out attention as a factor in the improvements
achieved (Zachor, Ben-Itzchak, Rabinovich & Lahat, 2007). Another study conducted
much the same way found intensive ABA treatment to produce gains in IQ, adaptive
behavior, and communication greater than those found in an equally intense eclectic
treatment group (Howard, Sparkman, Cohen, Green & Stanislaw, 2005). This finding
indicates that ABA treatment has the possibility to be more effective than eclectic
16

treatment even with equal amounts of time devoted to each intervention (Howard et al.,
2005). The only problem with this study is that there was no way for the researchers to
monitor the quality of the eclectic treatment as compared to the quality of the ABA based
treatment which could have affected the results.
Two studies investigated the efficacy of clinic-based treatment as compared to
parent-managed treatment and found that both were equally effective across all outcome
measures (Luiselli, Cannon, Ellis & Sisson, 2000; Hayward, Eikeseth, Gale & Morgan,
2009). These discoveries show that ABA treatment can be effectively carried out in an
environment other than a clinic which makes it much more accessible; however, the
implementation of these interventions in the home comes with its own problems.
Grindle, Kovshoff, Hastings, and Remington (2009) investigated parent experiences of
these home-based programs; they found that while most parents had positive things to say
about the programs there were still considerable negative effects experienced by the
families. The most common negative statements about these home-based ABA programs
include lack of privacy associated with having a therapist in the home full time, high
therapist turnover rates, siblings feeling left out or less time available for the parents to
care for them, significant financial stresses involved in paying for the program, and
deteriorating marital conditions (Grindle et al., 2009). These problems are significant
and should be considered by families before an intensive ABA program is implemented
in the home.
From the available literature a number of limitations inherent in both the research
and implementation of ABA are clear. First, the original studies conducted on the use of
ABA with children with ASD had significant methodological errors as well as faulty and
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misleading reporting of outcomes. Secondly, it has been proven in multiple studies that
the children most likely to benefit from ABA interventions are those who have the
highest IQ’s and the lowest level of autism severity. This limitation is significant
because the majority of children with ASD are not high functioning, implying that these
interventions are not as helpful for the majority of the population as the research would
imply. A third problem is that the data is inconclusive at best concerning the long-term
efficacy of these interventions. If the gains acquired through these programs are not
maintained long-term, then the parents who sacrifice a great deal of time and money to
enroll their children in ABA interventions are wasting these sacrifices and ending up
right back where they started. Fourth, ABA treatment is exceptionally expensive which
puts a great deal of strain on families who attempt to use this intervention to help their
children. Finally, the largest problem with ABA is that the research is not focused on
reducing disruptive behaviors, but rather using operant conditioning to teach trained
responses to certain stimuli. Research into alternative methods for reducing disruptive
behaviors is necessary.
Psychopharmacology
The second main research focus on therapeutic interventions for children with
ASD is psychopharmacology, and while ABA research has rarely targeted disruptive
behaviors, research into the use of atypical anti-psychotic medications has consistently
and nearly exclusively attempted to reduce these behaviors. Currently, the only
medications in the class that are approved for use in children with ASD are risperidone
and aripiprazole (Pringsheim et al., 2011). All of the research conducted into these
medications focuses on reducing a set of behaviors referred to as “irritability.” This term
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can be misleading since it is rarely formally defined in the literature. Generally speaking,
when researchers use the term “irritability” it describes the behaviors of aggression, selfinjury, and/or tantrums (Matson et al., 2011).
Based on some hypothesized causes of ASD, the literature has suggested that
antipsychotic medications may be beneficial in the treatment of disruptive behaviors. It
is suspected that some of the behaviors associated with ASD are linked to abnormalities
in some of the specific dopamine and serotonin synapses within the brain (Posey, Stigler,
Erickson, & McDougle, 2008). These specific synapses are targeted by antipsychotic
medications such as risperidone and aripiprazole which sparked the interest in using these
drugs for the treatment of ASD (Posey et al., 2008). A great number of reviews have
been conducted into the overall efficacy and amount of research available pertaining to
the major antipsychotic medications considered for use in children with ASD
(Benvenuio, Battan, Porfirio, & Curatolo, 2013; Robb, 2010; Malone & Waheed, 2009;
Malone, Gratz, Delaney & Hyman, 2005). The most commonly researched medications
are risperidone, aripiprazole, and haloperidol (a first generation anti-psychotic.) Multiple
studies have concluded that these medications are safe and effective, with risperidone and
aripiprazole preferred to haloperidol due to the lower risk of extra-pyramidal symptoms
(EPS) associated with their use (Benvenuio et al., 2013;Robb, 2010; Malone & Waheed,
2009; Malone et al., 2005). Only one study has been conducted that directly compares
the efficacy of risperidone and haloperidol; it found that risperidone was more effective,
and had less EPS than haloperidol, but had a higher chance of clinically significant
weight gain (Miral, Gencer, Inal-Emiroglu, B. Baykara, A, Baykara, & Dirik, 2008). A
limitation of the available research into these medications, however, is that the available
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body of literature does not examine all of the possible side effects or their relative
incidences in the population of children taking these medications. All of the above
studies suggest the use of atypical-antipsychotic medications, and only one of the four
studies (Malone & Waheed, 2009) suggests that monitoring the side effects of these drugs
is necessary.
Risperidone is one of only two drugs approved by the FDA for use in reducing
irritability in children with ASD, this approval was acquired after two large-scale
randomized double-blind placebo controlled drug trials conducted by the Research Units
on Pediatric Psychopharmacology Autism Network (RUPPAN) (Malone & Waheed,
2009). The first was an eight-week trial composed of 101 participants diagnosed with
ASD which compared the effects of risperidone to placebo using the aberrant behavior
checklist (ABC) as the predominant outcome measure (McCracken et al., 2002). This
study found risperidone to be superior to placebo in reducing irritability in children with
ASD (McCracken et al., 2002). The second was a four month open-label treatment with
a two-month double-blind placebo controlled discontinuation phase using the same
outcome measure (McCracken et al., 2002). In this trial risperidone was found to
continue to be effective in maintaining behavioral gains during the discontinuation phase;
it was concluded that the use of risperidone in children with ASD was safe and effective
(McCracken et al., 2002). In a separate study which used the same participants and
collected data simultaneously, it was found that risperidone was responsible for effecting
gains other than the reduction of irritability including the reduction of maladaptive
behaviors, stereotypical behaviors, and an increase in daily living skills but was not able
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to affect changes in either of the other two core symptom domains of ASD
(Communication deficiency, and impaired social skills) (McDougle et al., 2005).
These studies, however, are not the only ones that have investigated the efficacy
of risperidone. Both double-blind and open-label studies have been conducted and all of
these studies have found risperidone to be effective in reducing irritability with a claim of
few to no adverse effects (Pandina, Bossie, Youssef, Zhu, & Dunbar, 2007; Shea et al.,
2004; Nicolson, Awad, and Sloman, 1998). Risperidone has even been researched in
conjunction with other medications and therapy techniques in an attempt to prove its
effectiveness. Two studies conducted in Iran investigated the efficacy of the
simultaneous use of other medications with risperidone. The first investigated the
combination of risperidone with topiramate (an anticonvulsant) in a double-blind trial and
found risperidone and topiramate together to be more effective in reducing irritability
than placebo and risperidone in isolation (Rezzaei et al., 2010). A study with a similar
design and outcomes also compared the use of risperidone with pentoxifylline (a blood
thinner) and found in favor of using them together (Akhondzadeh et al., 2010). A major
limitation of these studies is that they do not fully address the adverse effects associated
with these medications. They suggest the use of the drugs without any real indications of
research into the negative effects that are possible.
One of the biggest problems with the use of these drugs is that they have a
number of unpleasant and uncontrollable side-effects that could cause life-altering
damage to the child taking them. Another problem is that continuing to take the
medication is required to maintain the behavioral benefits associated with it, meaning that
children end up taking the drugs for considerably longer time periods than the available
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research has investigated. Only two studies to date have investigated what they call the
“long-term” effects of these medications, a period of only six months (RUPPAN, 2005;
Troost et al., 2005). Both studies found risperidone to have continuing effectiveness over
time without the development of tolerance and that its continued use was necessary to
prevent relapse. Despite these findings, the authors suggest that drug therapies are not a
permanent solution and other treatment options are necessary to ensure the child
maintains their behavioral gains as the medication is tapered off (RUPPAN, 2005; Troost
et al., 2005). This is significant because these studies are the only randomized doubleblind controlled trials found to suggest that risperidone may not be the best solution to the
problem of disruptive behaviors. Both studies found significant weight gain among all of
the subjects, a problem that could lead to metabolic disorders at the time of treatment or
later in a child’s life (RUPPAN, 2005; Troost et al., 2005).
Aripiprazole is the second FDA approved antipsychotic medication used to reduce
irritability in children with ASD. It has been found in multiple studies, both open-label
and double blind, to be effective in reducing disruptive behaviors among children with
ASD (Marcus et al., 2009; Owen et al., 2009; Stigler et al., 2009). The most common
side effects reported from these studies included weight gain, EPS, decrease in prolactin
levels, and increases in aggression. The increase in aggression was also noted by Rugino
and Janvier (2005) when they investigated the prevalence of use as well as common sideeffects among all children prescribed aripiprazole. They found that increased aggression
was a common side effect only among children with ASD and was present in thirty-five
percent of the children with ASD included in the study (Rugino & Janvier, 2005). They
also found that aripiprazole was only effective in reducing pre-treatment aggression
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levels in twenty-five percent of the autistic subjects (Rugino & Janvier, 2005). This is
significant because many of the children who are placed on these medications are
prescribed them because of serious problems with aggression that could not be resolved
through other therapeutic measures. If aripiprazole is not effective in reducing
aggression and is capable of making aggression worse, then it is not a good choice for use
in this population. The findings from this article are in direct conflict with the findings of
a double-blind study comparing the efficacy of aripiprazole and risperidone. According
to the study aripiprazole and risperidone had similar efficacy in reducing irritability and
similar levels of side-effects (Ghanizadeh, Sahraeizadeh, & Berk, 2013). This conflict
points out an important limitation in the research into the efficacy of antipsychotic
medications in this population. Since the research focuses on reducing the blanket set of
behaviors termed “irritability,” it is difficult to isolate the relative efficacy of these drugs
on the specific symptoms included under that name (i.e. aggression, tantrums and/or selfinjurious behaviors). All of the studies on aripiprazole down play the symptoms
associated with this medication in a manner very similar to the risperidone literature.
This can skew the interpretation of the results as far as safety and tolerability of these
medications is concerned.
The only studies that truly investigate the prevalence of adverse effects associated
with these medications are conducted by separate authors and review the side-effects as
reported, or acquired through communication with the authors of the original projects.
All of these studies found that there are serious neurological, metabolic, and endocrine
adverse effects caused by these medications which are masked in the literature through
faulty reporting or misleading outcome measures used to evaluate the side-effects. Of
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particular note is the prevalence of EPS in children who take risperidone and aripiprazole,
particularly since these medications became popular for use in this population due to
being supposedly free of neurological complications (Mckinney, & Renk, 2011;
Pringsheim et al., 2011; Vitiello, Correll, Zwieten-Boot, Zuddas, Parellada, & Arango,
2009). Risperidone and aripiprazole have both been shown to cause weight gain, with
risperidone causing more significant weight gain than aripiprazole, and both medications
have been shown to affect prolactin levels (risperidone raises it, aripiprazole lowers it)
but the consequences of these effects have not been fully explored in this population
(De Hert, Dobbelaere, Sheridan, Cohen, & Correll, 2011; McKinney & Renk, 2011;
Pringsheim et al., 2011; Vitiello et al., 2009). All of these studies agree that the risks of
these medications are too great to be ignored and psychopharmacological treatment
should be used only as a last resort if it is used at all.
Another interesting omission in the literature surrounding the treatment of
disruptive behaviors in children with ASD is research into the combination and/or
comparison of ABA and risperidone as methods to reduce disruptive behaviors (Weeden
Ehrhardt, & Poling, 2009). These two treatment options are viewed as being mutually
exclusive in the literature when in reality as the two main schools of thought for treating
ASD they ought to be working together. One suggestion for why they are not used
together is that the two research strategies have fundamentally different methodologies
that are difficult to combine into a valid and coherent experiment (Weeden et al., 2009).
The only study discovered which remotely attempts to rectify this omission was
conducted in 2012 by RUPPAN into the efficacy of combining risperidone treatment with
parent training to reduce maladaptive behaviors in children with ASD. It was found that
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children whose parents underwent the training for how to manage disruptive behaviors in
their children had a significantly lower incidence of these maladaptive behaviors by the
end of the treatment than did children taking risperidone alone (Scahill et al., 2012). This
is important because the inclusion of parent training with a prescription of risperidone
may allow the child to end treatment faster and keep more of their gains after the
cessation of drug treatment. This has not been proven, however and a study to test this
concept would be difficult to implement.
Overall, while the research shows atypical anti-psychotic medications such as
risperidone and aripiprazole to be effective in reducing disruptive behaviors in children
with ASD, they have many draw-backs. The most serious of these is the large number of
adverse side-effects that are possible, the long-term effects of which have not been fully
investigated. Another issue is that no research has been appropriately conducted into the
long-term effects of these medications especially since they are generally prescribed for
very long periods of time. A final problem is that risperidone and other drugs like it are
not a permanent solution to the problem of disruptive behaviors, a child cannot be
expected to live the rest of their lives on a medication to control their behaviors.
Other Interventions
While there is much research into ABA and psychopharmacological interventions,
there is little research into the more unconventional treatment methods including sensory
integration therapy, auditory integration training (AIT), sensorimotor handling
techniques, and physical exercise (Baranek, 2002; Dawson & Watling, 2000). The
research that does exist involving these methods is predominantly inconclusive (Dawson
& Watling, 2000) with the most consistent positive gains seen through the incorporation
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of antecedent aerobic exercise into the intervention strategy (Baranek, 2002). In a
population of adults, vigorous antecedent aerobic exercise was found to reduce disruptive
behaviors and allow them to carry out jobs both in group homes and in the community
(Elliot et al., 1994). Auditory integration training was found to have the most negative
evidence and mostly inconclusive results in the studies available suggesting that this
intervention may not be effective, however due to the low quality of the data, it is
difficult to tell (Dawson & Watling, 2000). Sensory integration therapy has more
positive results but the limitations inherent in the study design prevent generalization of
the findings (Baranek, 2002). It is difficult to ascertain the effectiveness of these
interventions because there are serious limitations in the experimental design including
small population size, no control groups, presence of confounding variables, and a lack of
consistent outcome measures. Since these interventions have neither been proven
ineffective nor effective further research into these and other alternate strategies for
behavioral intervention in ASD is imperative (Baranek, 2002).
Balance Deficits in ASD
A lack of postural stability and balance is epidemic among individuals with ASD,
though it is rarely addressed in the literature. Improving postural stability is also
included infrequently in the interventions commonly used for children with ASD. A
number of studies have proven that there is a measurable deficit in balance among both
children and adults with ASD that persists throughout the lifetime (Fournier et al., 2014;
Memari et al., 2013; Fournier et al., 2010; Romero-Munguía, 2008; Minshew et al., 2007;
Shmid et al., 2006; Gowen, & Miall, 2005; Molloy et al., 2003). There is much
controversy as to what exactly causes these balance problems in children with ASD. One
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author suggests that the balance problems are due to poor sensory integration and an
over-reliance on visual cues to maintain balance (Molloy et al., 2003). Another was not
able to suggest any specific neurological complications, only a correlation between
autism severity and degree of instability (Memari et al., 2013). A study by Minshew et
al., (2007) supports the correlation between autism severity and degree of postural control
because they found that balance difficulties were not related to mental retardation, but
rather completely dependent on the presence of ASD. They also found that development
of postural control was significantly delayed and never reached appropriate adult levels
suggesting that this deficiency is persistent throughout the lifetime (Minshew et al.,
2007). Finally, it is suggested by the authors that their data disproves the assumption that
these postural control issues are due to a problem with the cerebellum as has been
reported by other authors (Gowen & Miall, 2005), but rather may be due to a dysfunction
of the basal ganglia, supplementary motor, and anterior cingulate regions of the brain
(Minshew et al., 2007).
A pair of studies conducted by Fournier et al. has important implications for the
application of balance training to children with ASD. The studies found that children
with ASD have decreased static and dynamic postural control and that these deficits
could be linked neurologically to the expression of stereotypical behaviors (Fournier et
al., 2014; Fournier et al., 2010). The authors recommend balance training as an
important treatment for children with ASD as it combats the natural deficits in this
important mechanism (Fournier et al., 2014; Fournier et al., 2010). The link between
stereotypical behaviors and reduced postural control in children with ASD is particularly
important because it demonstrates that there may be a neurological basis to suppose that
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improving balance in children with ASD through balance training may reduce disruptive
behaviors (such as stereotypies).
An easy assumption to make is that children who have poor balance are more
likely to have difficulty carrying out complex cognitive tasks. If these children have to
spend all of their time focusing on keeping themselves from falling, then this increased
difficulty in performing basic tasks may cause children to act out in an effort to escape
from the demanding situation. This assumption is supported by a study conducted into
the association between concurrent cognitive tasks and balance. In this study, it was
found that children who were asked to complete a complex cognitive task while
attempting to stand still had significantly lower levels of postural control than when they
had no concurrent cognitive task (Schmid et al., 2007). It is not difficult to turn this
finding around. Though more difficult to prove, it would make sense that the greater
amount of mental energy needed to maintain balance (the level of postural instability),
the more difficult it would be for a child to carry out complex cognitive tasks. This
supposition is supported by a cognitive theory developed by Romero-Munguía called
Mnesic imbalance. It suggests that the problems associated with ASD particularly
balance deficiency can all be explained by a disruption in procedural memory (RomeroMunguía, 2008). He suggests that this deficiency in procedural learning requires children
with ASD to use their conscious thought to avoid falling since they are not able to move
information from declarative to procedural memory and therefore transfer the motor
skills to unconscious control (Romero-Munguía, 2008). This may be related to disruptive
behaviors because children who must consciously prevent themselves from falling do not
have enough mental energy left over to control their own behaviors.
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No research has been conducted as of yet on what the benefits of balance training
on children with ASD are and certainly none has been conducted into its effect on
disruptive behaviors. It seems clear from the evidence that there must be a connection
between these two sets of symptoms. Overall, there are many limitations to the current
lines of research into the reduction of disruptive behaviors and it is important to
individuals with ASD and the community as a whole that sustainable, safe, practical, and
effective intervention strategies for reducing these behaviors be researched. Balance
training has the capability to provide an intervention that meets all of these criteria and it
has not been previously researched thus calling for investigation into balance training as
an intervention to reduce disruptive behaviors in children with ASD. This research hopes
to answer the question what is the effect of balance training on disruptive behaviors in
children with ASD?
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Chapter 3: Methods

Since the current literature has suggested that it is possible for balance training to
positively affect behavior, this study investigated that possibility. This study was
approved by the Institutional Review Board (IRB) at the University of Southern
Mississippi (USM).
Sample
The sample for this study consisted of fourteen parents of children with ASD aged
between two and eighteen years old. This age range was selected in an effort to
maximize sample size due to the low availability of study participants. This sample was
acquired through contacting various therapy centers in the Hattiesburg and Jackson areas
and the Dubard School on USM’s campus. The sample was broken down into two
groups one composed of parents of children who have been engaged in therapy programs
that include a balance training component for more than one year and another of parents
of children who were engaged in therapy programs that did not include a balance training
component or have participated for less than a year. This allowed for comparison
between groups of children who had differing exposure to balance training in an attempt
to detect an effect on disruptive behaviors. The control group contained six participants
and consisted of individuals whose children had less than a year of balance training or
none at all. The experimental group contained eight participants and consisted of
participants whose children had more than a year of balance training.
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Variables
The dependent variable was the level of disruptive behaviors exhibited by the
children while the independent variable was the incorporation of balance training into
these children’s therapy programs. Disruptive behaviors were defined as aggression,
stereotypies, and non-compliance. The children must have exhibited these behaviors on a
semi-regular basis (i.e. at least once a week) to qualify as having disruptive behavior
problems. In general, balance training programs are incorporated into physical therapy,
occupational therapy, and therapeutic riding programs. Balance training programs from
these various therapies are identified as such by the therapist who prescribed them thus
allowing parents to know their child is engaged in balance training.
Instrumentation
The norm-referenced Aberrant Behavior Checklist (ABC) was the primary
outcome measure used to determine the severity of disruptive behaviors. Three of the
five subscales were used as follows: irritability, stereotypic behaviors, and
hyperactivity/noncompliance. These subscales were chosen because they measure the
main disruptive behavior markers that this study was concerned with investigating. A
separate survey written by the author was used to establish baseline demographic data
such as current age, age when intervention was begun, gender, specific ASD diagnosis,
type of intervention/therapy program, the presence or absence of balance training in said
program and length of time involved in the intervention. All of these materials are
contained in Appendix A: Survey Packet.
Procedure
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Physical therapy clinics, the Jackson Autism Center, the Dubard School and
therapeutic riding centers were contacted to acquire permission to leave survey packets
for the therapists to disseminate to the parents of autistic children who attend those
centers. The therapists in charge of treatment at each center signed two brief verification
forms which established both if the therapist does or does not engage in balance training
in their programs and that the participants they recruited do have children with autism.
After reading the information letter and signing the consent form, one parent from each
family filled out the demographic information questionnaire as well as the ABC. The
questionnaires were collected by the researcher two weeks from the first day that they
were sent to each therapy center. In cases with an insufficient response, the clinics were
contacted again and the therapists requested to ask their parents again to complete the
surveys. In most cases the therapy center did not respond to the second attempt at contact
so the sample size was limited both by available subject recruitment pools and by low
participation rates.
Data Analysis
The raw data obtained from the three subscales of the ABC was analyzed using
IBM’s Statistical Package for the Social Sciences (SPSS) version twenty-two. In all
tests, p<0.05 was used to indicate significance. To determine if there was an overall
difference between the control and experimental groups, the data was analyzed using
Multivariate Analysis of Variance techniques (specifically the Hotelling’s Trace test) in
order to determine if there was a significant difference between the groups overall when
all three dependent variables were taken into account. Due to the small sample size, the
individual variables were also analyzed for significance independent of each other using
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an Independent Sample T-test that was corrected for differences in sample size and
unequal variance as appropriate. For this analysis, the data was split not only into the
control and experimental group, but also other groupings based on the available
information on other therapeutic interventions provided by the participants. Due to the
lack of sufficient survey response, the sample size was smaller than optimal which
limited the power of the statistical analyses to detect differences and limited
generalization.
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Chapter 4: Results

Participants
A total of fourteen participants were recruited for this study of these, twelve were
male and two were female. There were no differences between groups on which parent
(mother or father) filled out the survey, but both of the female participants were in the
control group. On average, compared to the experimental group, the participants in the
control group tended to be younger (= 7.4 yrs vs. = 11.1 yrs), have a lower severity of
Autism (based on self-reported diagnosis), participated in therapy programs for a lower
total number of years (= 3.4 yrs vs. = 8 yrs), were more likely to participate in ABA
interventions (83.3% vs. 25%), and were less likely to use psychopharmacologic
interventions (16.67% vs. 66.67%). The sample was also grouped by presence of ABA
interventions and the presence of drug interventions in the therapy program as part of the
follow-up analyses. All of these demographic measures are summarized in Table I:
Demographic Measures below.
Table I: Demographic Measures
Grouping
Variable
Balance

Age
Autism
(years) Severity

Years in
Therapy

Balance
training

ABA

Drug
Intervention

N

Yes

11.1

High

8

100%

25%

16.67%

8

No

7.4

Low

3.4

0%

83%

66.67%

6

ABA Yes Yes

8.9

Medium

6.2

42.8%

100%

42.8%

7

No

10.1

Medium

5.7

71.4%

0%

28.5%

7

Drug
Yes
Therapy N
No
o

11.2

High

9.2

40%

80%

100%

5

8.6

Low

4.3

44%

33%

0%

9

Yes
No

No
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Efficacy
There was not a statistically significant difference in incidence of disruptive
behaviors based on the presence of balance training in the therapy program when all three
dependent variables were taken into account simultaneously, F(3,10)= 2.278 p>0.05;
Hotelling’s Trace= 0.683 (see Table II: Multivariate Analysis). This lack of significance
is likely attributable to small sample size. When analyzed individually using a one tailed
t-test (p=0.05) the results on irritability, stereotypy, and hyperactivity also all failed to
reach significance with p= 0.207, p= 0.98, and p= 0.614 respectively. Similar results
were found when the data was broken up into groups based on ABA and Drug
intervention strategies wherein none of the variables reached significance on a two tailed
t-test (p=0.05). Notably, when the sample was grouped based on total number of
therapeutic interventions (>5 vs. <5) the irritability variable just failed to reach
significance with p= 0.073. This data is summarized in Table III: Univariate Analysis
on the next page.
Table II: Multivariate Analysis
Effect

Value

F

Hypothesis df Error df

Significance*

Pillai’s Trace

0.406

2.278

3.000

10.000

0.142

Wilks’ Lambda

0.594

2.278

3.000

10.000

0.142

Hotelling’s Trace

0.683

2.278

3.000

10.000

0.142

0.683

2.278

3.000

10.000

0.142

Roy’s Largest Root
significant at p< 0.05 level

*
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Table III: Univariate Analysis
Group
Balance

Yes

No

ABA

Yes

No

Drug
Intervention

Yes

No

Number of
Therapies

≥5

<5

N

Mean

Std. Dev.

Sig.

Irritability

8

6.875

4.969

0.207

Stereotypy

8

6.750

3.807

0.980

Hyperactivity

8

16.875

14.095

0.614

Irritability

6

9.333

5.921

-

Stereotypy

6

2.833

1.834

-

Hyperactivity

6

15.000

7.071

-

Irritability

7

7.285

4.820

0.670*

Stereotypy

7

5.714

4.347

0.529*

Hyperactivity

7

18.857

14.346

0.376*

Irritability

7

8.571

6.106

-

Stereotypy

7

4.428

2.935

-

Hyperactivity

7

13.285

7.181

-

Irritability

5

8.000

8.455

0.979*

Stereotypy

5

4.000

3.082

0.432*

Hyperactivity

5

15.600

15.962

0.913*

Irritability

9

7.888

3.218

-

Stereotypy

9

5.666

3.937

-

Hyperactivity

9

16.333

8.888

-

Irritability

6

10.666

6.623

0.073

Stereotypy

6

5.833

4.875

0.259

Hyperactivity

6

21.666

15.174

0.091

Irritability

8

5.875

3.181

-

Stereotypy

8

4.500

2.563

-

Hyperactivity

8

11.875

4.696

-

*indicates 2-tailed test
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Chapter 5: Discussion

Findings
This study presents data on fourteen children, eight of whom were engaged in
balance training for more than a year and six of whom were engaged in balance training
for less than a year or not at all. There were no statistically significant differences in
overall incidence of disruptive behavior between the control and experimental groups.
There were also no statistically significant differences in irritability, stereotypy, or
hyperactivity between the groups when these variables were analyzed individually. The
small sample size likely caused the difficulty in detecting significant differences between
the groups. This conclusion is supported by the follow-up analyses conducted by
splitting the sample into two further groupings, one based on participation in ABA
interventions and the other based on participation in drug interventions. Neither of these
groupings was capable of detecting a significant difference in any of the disruptive
behaviors measured despite the fact that both interventions have been shown by other
researchers to have statistically significant effects (Ben-Itzchak & Zachor, 2007; Malone
& Waheed, 2009). Notably, when the sample was grouped based solely on the number of
interventions used (less than five or greater than five) it was found that the scores on the
irritability subscale of the ABC just failed to reach significance with p= 0.07. This
suggests that having a more diverse set of therapies may be more beneficial than having
only one, an observation which was not made in the ABA or pharmacologic research
reviewed.
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Another possible reason that the data failed to reach significance is due to the
differences between the study groups. The two groups had very different make ups over
all, and these differences were amplified during analysis by the small sample size. On
average, the participants in the experimental group tended to be older and have a much
higher severity of Autism (based on self-reporting by the parents of the child’s diagnosis)
compared to the control group. This difference in Autism severity may have led to a
masking of the treatment effect since, according to the DSM-IV-TR; higher degrees of
Autism severity tend to lead to increased rates of disruptive behaviors (American
Psychiatric Association, 2000). This possible increase in disruptive behaviors with autism
severity would easily have masked any treatment effects in the small sample especially
due to the inability to collect pre-treatment measures of disruptive behavior.
Limitations
There were a number of methodological issues with this study that may have
affected the interpretation of the findings; the largest of which was the method of subject
recruitment and assignment to groups. The sample was a convenient one, taken from
various therapy centers whose directors were willing to participate in the research. There
was no way to recruit the subjects from diverse locations or to ensure an even distribution
of secondary characteristics such as age, gender, autism severity, ethnicity, or
socioeconomic status, this increases the risk of confounding variables in the research and
reduces the generalizability of the findings. The study also used a Quasi-Experimental
design wherein the participants were not randomly assigned to the treatment states;
rather, the participants were sorted into groups based on what therapies they have chosen
to do. This method resulted in the experimental group having a higher level of Autism
38

Severity than the control group which likely masked any treatment effect that could have
been detected at this small sample size.
Another methodological issue with this study is that the data was taken through
parent completed surveys. Survey based studies are difficult to interpret due to the
number of uncontrolled variables inherent in this data collection method. Although as
many variables were controlled as possible, the researcher had no way of confirming if
the information listed in the demographic questionnaire or the ABC was true.
Another problem with this study was the small sample size. After spending
nearly seven months contacting therapy centers to get their permission to distribute
surveys to their locations, only five centers consented to participate and only three of
those returned completed surveys. Of the fifty surveys distributed only fourteen were
returned completed and only one center returned the blank ones with the completed ones.
The small sample size also forced compromises to be made in the control and
experimental groupings. Because only two surveys were returned that indicated the
children participated in no balance training at all, the groups had to be split based on
length of time in the balance program which severely weakened the integrity of the
research.
Recommendations for Future Research
With all of the research indicating that all individuals with ASD have some sort of
balance deficit, it is important to determine exactly what effect improving the balance of
children with ASD has not only on their behaviors but on their general quality of life.
Future research into this topic should be paramount among Autism researchers. Due to
the inconclusive nature of the results of this study, it is important to repeat the study with
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a larger participant base and in a way that minimizes the methodological problems
experienced in this first attempt. Further research into this topic should also include
longitudinal research that follows children from their first entrance into a balance
program all the way until they are discharged from therapy services. It will be important
to discover which type of balance (static or dynamic or both) improvements are the most
beneficial for these children because this knowledge will allow more focused therapeutic
programs to be created for these individuals.
Due to the finding that the number of therapies (regardless of type) that the
children participated in had a nearly significant effect on reducing irritability, another
interesting avenue of research would be to determine if the number of therapies a child is
involved in increases their functionality. So much of the research into treatments for
Autism, this study included, has focused on finding the one most effective treatment to
reduce the difficulties associated with Autism. A study into if the quantity of therapeutic
interventions applied is more advantageous than the type of individual interventions
would be an interesting addition to the literature.
Conclusions
Overall, it is crucial that the effect of balance training on children with ASD be
determined because until there is sufficient research backing the intervention, it will be
difficult for parents to get appropriate treatment for their children. Despite the
methodological problems with this study and the inconclusive results it is still paramount
to discover what effect balance training has on these individuals. Despite all of the
individual variation in children with ASD all of them have some form of balance deficit a
unilateral similarity that is not true of any other element of the disorder. It is important to
40

determine how improvements in balance can help the whole of this population. The
biggest benefit to balance training is that it has no dangerous side effects (like the drug
therapies), it does not require thousands of dollars and hours of work (like ABA), and it
has the potential to improve the lives of every child with ASD not only the few that have
the specific problems targeted by other interventions. This study has shown that future
research into this topic is paramount to discovering further treatments that can help this
ever increasing population.
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Appendix A: Survey Packet

Introduction

Please read this letter before completing the included
surveys.
To Whom it may concern:
My name is Claire Scates and I am a senior honor’s student at the University of
Southern Mississippi. As part of my degree, I have to complete an original research
project for my honor’s thesis.
The purpose of my project is to investigate the effect (if any) of balance training
on disruptive behaviors in children with Autism Spectrum Disorders. I hope to
accomplish this through the data collected in these surveys. You will complete a brief
demographic questionnaire and a longer survey. Based on your answer to the question on
the next page that asks “what therapies your child has been involved in or is currently
involved in” your results will be sorted into two groups. The first group will include only
those children who are involved in some sort of balance therapy and the second will
include only those children who do not have any balance improving therapies.
Balance is defined as the ability to control the body’s center of gravity within a
given base of support. Simply put balance is your ability to keep control of your body so
you do not fall. Common methods employed in therapy settings to improve a child’s
balance include but are not limited to the following: BOSU ball exercises, standing on
balance boards(sometimes called wobble boards) strengthening the core (abdominal)
muscles, and therapeutic riding. Testing of balance is commonly conducted through the
Romberg test where the child will stand on both feet with the eyes closed and their ability
to maintain that position is monitored.
The survey you are about to complete is called the Aberrant Behavior Checklist
(ABC) and is a norm-referenced scale used to assess the frequency and severity of
disruptive behaviors among children, teens, and adults. The ABC is designed to be
completed by parents based on their observations of their child’s recent behavior. The
results from this checklist will be used to calculate the relative amounts of disruptive
behaviors exhibited by the two sample groups in the study (one whose therapies include
balance training and one whose do not).
Thank you so very much for helping me with this. Your answers to this survey
will be kept completely confidential and will never be associated with yours or your
child’s name. Ignore the blanks on the entire first page of the Aberrant Behavior
Checklist (pink survey) that ask for name, educational status, ethnicity, specific
medications, etc. as it is not necessary for you to provide that information.
Thank you,
Claire Scates
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Demographic Information

1. Parent filling out survey

Mother

Father

2. Age of Child- ____________
3. Gender of Child M

F

4. Specific Autism Diagnosis- ____________________
4. Total years involved in therapy programs- _____________
5. Please check all therapies your child is currently involved in as well as any they have
ever been involved in, then indicate approximately how many years they participated in
each therapy.

✓

Therapy

Years of Participation

Physical Therapy
-does this include a balance component

Yes

No

Occupational Therapy
-does this include a balance component

Yes

No

Speech Therapy
Therapeutic Riding
Applied Behavior Analysis
Psychopharmacologic Interventions (ex: Risperdal, Abilify, etc.)
TEACCH
Sensory Integration Therapy
Auditory Integration Therapy
Other (Please List): ______________________________
______________________________________________
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